What is Navigation Bronchoscopy?

According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in men and women, leading to more deaths than breast, colon and prostate cancers combined. In a recent study from The New England Journal of Medicine, though, patients with Stage I lung cancer had an 88% survival rate at 10 years. Early detection of lung cancer is critical. The traditional bronchoscope can’t reach many lung lesions, leading to delays in treatment or the need for more invasive procedures. A new minimally invasive procedure, navigation bronchoscopy, plays a key role in successful early diagnosis and treatment of lung cancer. This innovative technology is currently only available in a few metro Denver area hospitals, including The Medical Center of Aurora Main Campus.

The superDimension i-Logic System, or Electromagnetic Navigation Bronchoscopy (ENB) works like a GPS tracking system in locating a tumor for biopsy. Through electromagnetic technology and software, the system is able to use natural airway access to reach regions deep in the lung in order to locate small lung lesions for testing and treatment. If a lung CT Scan is suspicious, the i-Logic planning software uses the CT image to map the location to the lesion. Global Positioning System (GPS)-like technology is then used during the procedure to lead specialized catheters to the lesion through the patient’s airways. A biopsy is then obtained for testing, diagnosis and possible treatment.

Benefits

  • Minimally invasive outpatient procedure 
  • Efficient and reduced risk for complications
  • Access to hard to reach lung lesions
  • Many lung cancer patients are not surgical candidates
  • Multi-specialty
  • Effective
  • Improved visualization